Where next with therapy in advanced neuroblastoma?
Open Access
- 1 March 1990
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 61 (3) , 351-353
- https://doi.org/10.1038/bjc.1990.77
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- CARBOPLATIN OR CISPLATIN?The Lancet, 1989
- Screening for neuroblastoma.BMJ, 1988
- Ifosfamide in previously untreated disseminated neuroblastomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Long-Term Survival after Advanced NeuroblastomaNew England Journal of Medicine, 1987
- High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation studyEuropean Journal of Cancer and Clinical Oncology, 1987
- Single-Agent Ifosfamide in Patients with Recurrent Neuroblastoma (Ensg Study 2)Pediatric Hematology and Oncology, 1987
- Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantationCancer Chemotherapy and Pharmacology, 1986
- Neuroblastoma-An Overview of Laboratory Studies Aimed at Inducing Tumor Regression by Initiation of Differentiation or Administration of Antitumor DrugsPediatric Hematology and Oncology, 1986
- Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastomaNature, 1985
- Chemotherapy of advanced neuroblastoma: does adriamycin contribute?Archives of Disease in Childhood, 1981